TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Vistin Pharma AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
287,675
|
275,812
|
253,159 |
Financial expenses |
11,279
|
7,674
|
23,204 |
Earnings before taxes |
-3,635
|
35,274
|
37,685 |
Total assets |
404,516
|
317,792
|
224,458 |
Current assets |
157,747
|
123,083
|
79,197 |
Current liabilities |
279,114
|
189,103
|
81,244 |
Equity capital |
54,178
|
54,831
|
28,335 |
- share capital |
100
![]() |
100
|
33 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
13.4%
|
17.3%
|
12.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-1.3%
|
12.8%
|
14.9% |
Return on assets (ROA) |
1.9%
|
13.5%
|
27.1% |
Current ratio |
56.5%
|
65.1%
|
97.5% |
Return on equity (ROE) |
-6.7%
|
64.3%
|
133.0% |
Change turnover |
11,863
|
22,653
|
25,030 |
Change turnover % |
4%
|
9%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.